COURAGE under fire: on the management of stable coronary disease

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Trials

Background:

• The COURAGE trial evaluated the efficacy of coronary interventional procedures as initial therapy for stable coronary artery disease (CAD).
• Findings suggested limited added benefit of interventions compared to optimal medical therapy (OMT) alone.
• The trial faced criticisms regarding its design, procedural quality, and applicability to contemporary practice.

Purpose of the Study:

• To reevaluate the evidence supporting the COURAGE trial's findings.
• To address specific criticisms concerning trial design, procedural execution, and clinical relevance.
• To reaffirm the COURAGE trial's contribution to managing stable coronary artery disease.

Main Methods:

• Systematic review and reanalysis of data from the COURAGE trial.
• Critical appraisal of criticisms regarding trial design and interventional procedure quality.
• Assessment of the applicability of COURAGE findings to current clinical practice.

Main Results:

• The reevaluation found the COURAGE trial design to be appropriate and its findings robust.
• Evidence did not support claims of suboptimal coronary interventional procedures within the trial.
• The trial's results remain highly relevant for guiding management decisions in stable CAD.

Conclusions:

• The COURAGE trial provides crucial, relevant information for clinicians managing stable coronary artery disease.
• Coronary interventional procedures, when used as initial therapy, offer limited additional benefit over OMT.
• The trial's conclusions support a conservative approach, emphasizing OMT, for selected stable CAD patients.